Steven R Nesheim1, Laurie Linley2, Kristen M Gray2, Tianchi Zhang3, Jing Shi4, Margaret A Lampe1, Lauren F FitzHarris1,3. 1. Epidemiology Branch, Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA. 2. HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Centers for Disease Control and Prevention, Atlanta, GA. 3. ICF. 4. CDC Foundation, Atlanta, GA.
Abstract
BACKGROUND: Diagnoses of HIV infection among children in the United States have been declining; however, a notable percentage of diagnoses are among those born outside the United States. The impact of foreign birth among children with diagnosed infections has not been examined in the United States. METHODS: Using the Centers for Disease Control and Prevention National HIV Surveillance System, we analyzed data for children aged <13 years with diagnosed HIV infection ("children") in the United States (reported from 50 states and the District of Columbia) during 2008-2014, by place of birth and selected characteristics. RESULTS: There were 1516 children [726 US born (47.9%) and 676 foreign born (44.6%)]. US-born children accounted for 70.0% in 2008, declining to 32.3% in 2013, and 40.9% in 2014. Foreign-born children have exceeded US-born children in number since 2011. Age at diagnosis was younger for US-born than foreign-born children (0-18 months: 72.6% vs. 9.8%; 5-12 years: 16.9% vs. 60.3%). HIV diagnoses in mothers of US-born children were made more often before pregnancy (49.7% vs. 21.4%), or during pregnancy (16.6% vs. 13.9%), and less often after birth (23.7% vs. 41%). Custodians of US-born children were more often biological parents (71.9% vs. 43.2%) and less likely to be foster or nonrelated adoptive parents (10.4% vs. 55.1%). Of 676 foreign-born children with known place of birth, 65.5% were born in sub-Saharan Africa and 14.3% in Eastern Europe. The top countries of birth were Ethiopia, Ukraine, Uganda, Haiti, and Russia. CONCLUSIONS: The increasing number of foreign-born children with diagnosed HIV infection in the United States requires specific considerations for care and treatment.
BACKGROUND: Diagnoses of HIV infection among children in the United States have been declining; however, a notable percentage of diagnoses are among those born outside the United States. The impact of foreign birth among children with diagnosed infections has not been examined in the United States. METHODS: Using the Centers for Disease Control and Prevention National HIV Surveillance System, we analyzed data for children aged <13 years with diagnosed HIV infection ("children") in the United States (reported from 50 states and the District of Columbia) during 2008-2014, by place of birth and selected characteristics. RESULTS: There were 1516 children [726 US born (47.9%) and 676 foreign born (44.6%)]. US-born children accounted for 70.0% in 2008, declining to 32.3% in 2013, and 40.9% in 2014. Foreign-born children have exceeded US-born children in number since 2011. Age at diagnosis was younger for US-born than foreign-born children (0-18 months: 72.6% vs. 9.8%; 5-12 years: 16.9% vs. 60.3%). HIV diagnoses in mothers of US-born children were made more often before pregnancy (49.7% vs. 21.4%), or during pregnancy (16.6% vs. 13.9%), and less often after birth (23.7% vs. 41%). Custodians of US-born children were more often biological parents (71.9% vs. 43.2%) and less likely to be foster or nonrelated adoptive parents (10.4% vs. 55.1%). Of 676 foreign-born children with known place of birth, 65.5% were born in sub-Saharan Africa and 14.3% in Eastern Europe. The top countries of birth were Ethiopia, Ukraine, Uganda, Haiti, and Russia. CONCLUSIONS: The increasing number of foreign-born children with diagnosed HIV infection in the United States requires specific considerations for care and treatment.
Authors: Mark J Papania; Gregory S Wallace; Paul A Rota; Joseph P Icenogle; Amy Parker Fiebelkorn; Gregory L Armstrong; Susan E Reef; Susan B Redd; Emily S Abernathy; Albert E Barskey; Lijuan Hao; Huong Q McLean; Jennifer S Rota; William J Bellini; Jane F Seward Journal: JAMA Pediatr Date: 2014-02 Impact factor: 16.193
Authors: Sophie Cohen; Colette Smit; Annemarie M C van Rossum; Pieter L A Fraaij; Tom F W Wolfs; Sibyl P M Geelen; Elisabeth H Schölvinck; Adilia Warris; Henriette J Scherpbier; Dasja Pajkrt Journal: AIDS Date: 2013-10-23 Impact factor: 4.177
Authors: Ali Judd; Katja Doerholt; Pat A Tookey; Mike Sharland; Andrew Riordan; Esse Menson; Vas Novelli; E G Hermione Lyall; Janet Masters; Gareth Tudor-Williams; Trinh Duong; Di M Gibb Journal: Clin Infect Dis Date: 2007-08-27 Impact factor: 9.079
Authors: Bukola Salami; Higinio Fernandez-Sanchez; Christa Fouche; Catrin Evans; Lindiwe Sibeko; Mia Tulli; Ashley Bulaong; Stephen Owusu Kwankye; Mary Ani-Amponsah; Philomina Okeke-Ihejirika; Hayat Gommaa; Kafuli Agbemenu; Chizoma Millicent Ndikom; Solina Richter Journal: Int J Environ Res Public Health Date: 2021-03-28 Impact factor: 3.390